DNAJC15 and metabolic dysfunction-associated steatotic liver disease: Thus, targeting MCJ in the liver is a alternative safe approach to treat NAFLD as it prevents lipid accumulation by boosting mitochondrial respiration and β-oxidation without causing oxidative stress in the liver or ketosis.